Campral

Campral is a brand name of acamprosate, approved by the FDA in the following formulation(s):

CAMPRAL (acamprosate calcium - tablet, delayed release; oral)

• 
  Manufacturer: FOREST LABS
  
  Approval date: July 29, 2004
  
  Strength(s): 333MG ^[RLD]

Has a generic version of Campral been approved?

No. There is currently no therapeutically equivalent version of Campral available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Campral. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Campral.

See also...

• Campral Consumer Information (Drugs.com)
• Campral Consumer Information (Wolters Kluwer)
• Campral Consumer Information (Cerner Multum)
• Campral Advanced Consumer Information (Micromedex)
• Campral AHFS DI Monographs (ASHP)
• Acamprosate Consumer Information (Wolters Kluwer)
• Acamprosate Consumer Information (Cerner Multum)
• Acamprosate Advanced Consumer Information (Micromedex)
• Acamprosate Calcium AHFS DI Monographs (ASHP)